Deka Bank Deutsche Girozentrale Allakos Inc. Transaction History

Deka Bank Deutsche Girozentrale

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$5.08 - $9.81 $5,689 - $10,987	-1,120 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$8.55 - $111.89 $142,528 - $1.87 Million	-16,670 Reduced 93.7%	1,120 $11,000
Q1 2021 Apr 28, 2021	BUY	$109.73 - $153.66 $122,897 - $172,099	1,120 Added 6.72%	17,790 $1.94 Million
Q4 2020 Mar 12, 2021	SELL	$79.58 - $152.45 $66,051 - $126,533	-830 Reduced 4.74%	16,670 $2.38 Million
Q3 2020 Oct 29, 2020	BUY	$66.43 - $90.99 $1.16 Million - $1.59 Million	17,500 New	17,500 $1.38 Million
Q1 2019 May 10, 2019	SELL	$33.79 - $51.99 $506,850 - $779,850	-15,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$31.59 - $62.65 $473,850 - $939,750	15,000 New	15,000 $778,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $85.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.